Intranasal Dexmedetomidine Versus Oral Paracetamol as a Pre-anaesthetic Medication in Pediatric Age Group

• Status: Recruiting
• Trial end date: 2022-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Pre-operative anxiety is a major problem in children because it produces undesired results on induction and postoperative outcome. Dexmedetomidine is a highly specific alpha 2 adrenergic receptor agonist. Studies suggest that Dexmetomidine administration is safe as it is less invasive and have a short half-life.

Paracetamol is a potent physical pain killer. It also reduces psychological reactivity and blunts physical and social pain.

Adenotonsillectomy is one of the most common surgeries performed in pediatric age groups, so it is important to reduce pre-operative anxiety in those children.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Benha University
• Treatments: Acetaminophen; Dexmedetomidine

Criteria

Inclusion Criteria:

• The patients who are clinically free or with controlled medical condition [ASA I or ASA II].

• Age between 2 to 8 years.

Exclusion Criteria:

• ASA III or ASA IV.

• Age greater than 8 years.

• Parents' refusal to participate in the study.

• Patients with obstructive sleep apnea.

• Patients with known allergy or hypersensitivity reaction to any of the drugs used in the study.

• Patients with nasal infection or nasal pathology.